Literature DB >> 22674434

Structures and free energy landscapes of aqueous zinc(II)-bound amyloid-β(1-40) and zinc(II)-bound amyloid-β(1-42) with dynamics.

Olivia Wise-Scira1, Liang Xu, George Perry, Orkid Coskuner.   

Abstract

Binding of divalent metal ions with intrinsically disordered fibrillogenic proteins, such as amyloid-β (Aβ), influences the aggregation process and the severity of neurodegenerative diseases. The Aβ monomers and oligomers are the building blocks of the aggregates. In this work, we report the structures and free energy landscapes of the monomeric zinc(II)-bound Aβ40 (Zn:Aβ40) and zinc(II)-bound Aβ42 (Zn:Aβ42) intrinsically disordered fibrillogenic metallopeptides in an aqueous solution by utilizing an approach that employs first principles calculations and parallel tempering molecular dynamics simulations. The structural and thermodynamic properties, including the secondary and tertiary structures and conformational Gibbs free energies of these intrinsically disordered metallopeptide alloforms, are presented. The results show distinct differing characteristics for these metallopeptides. For example, prominent β-sheet formation in the N-terminal region (Asp1, Arg5, and Tyr10) of Zn:Aβ40 is significantly decreased or lacking in Zn:Aβ42. Our findings indicate that blocking multiple reactive residues forming abundant β-sheet structure located in the central hydrophobic core and C-terminal regions of Zn:Aβ42 via antibodies or small organic molecules might help to reduce the aggregation of Zn(II)-bound Aβ42. Furthermore, we find that helix formation increases but β-sheet formation decreases in the C-terminal region upon Zn(II) binding to Aβ. This depressed β-sheet formation in the C-terminal region (Gly33-Gly38) in monomeric Zn:Aβ42 might be linked to the formation of amorphous instead of fibrillar aggregates of Zn:Aβ42.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22674434      PMCID: PMC4886726          DOI: 10.1007/s00775-012-0909-9

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  55 in total

1.  Zinc ions promote Alzheimer Abeta aggregation via population shift of polymorphic states.

Authors:  Yifat Miller; Buyong Ma; Ruth Nussinov
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-06       Impact factor: 11.205

2.  A temperature predictor for parallel tempering simulations.

Authors:  Alexandra Patriksson; David van der Spoel
Journal:  Phys Chem Chem Phys       Date:  2008-02-25       Impact factor: 3.676

3.  Oligomerization and toxicity of beta-amyloid-42 implicated in Alzheimer's disease.

Authors:  O M El-Agnaf; D S Mahil; B P Patel; B M Austen
Journal:  Biochem Biophys Res Commun       Date:  2000-07-14       Impact factor: 3.575

4.  Metal binding modes of Alzheimer's amyloid beta-peptide in insoluble aggregates and soluble complexes.

Authors:  T Miura; K Suzuki; N Kohata; H Takeuchi
Journal:  Biochemistry       Date:  2000-06-13       Impact factor: 3.162

5.  High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.

Authors:  L Mucke; E Masliah; G Q Yu; M Mallory; E M Rockenstein; G Tatsuno; K Hu; D Kholodenko; K Johnson-Wood; L McConlogue
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

6.  Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

Authors:  D M Walsh; A Lomakin; G B Benedek; M M Condron; D B Teplow
Journal:  J Biol Chem       Date:  1997-08-29       Impact factor: 5.157

Review 7.  A beta oligomers - a decade of discovery.

Authors:  Dominic M Walsh; Dennis J Selkoe
Journal:  J Neurochem       Date:  2007-02-05       Impact factor: 5.372

8.  NMR studies of the Zn2+ interactions with rat and human beta-amyloid (1-28) peptides in water-micelle environment.

Authors:  Elena Gaggelli; Anna Janicka-Klos; Elzbieta Jankowska; Henryk Kozlowski; Caterina Migliorini; Elena Molteni; Daniela Valensin; Gianni Valensin; Ewa Wieczerzak
Journal:  J Phys Chem B       Date:  2007-12-12       Impact factor: 2.991

9.  Identifying the minimal copper- and zinc-binding site sequence in amyloid-beta peptides.

Authors:  Velia Minicozzi; Francesco Stellato; Massimiliano Comai; Mauro Dalla Serra; Cristina Potrich; Wolfram Meyer-Klaucke; Silvia Morante
Journal:  J Biol Chem       Date:  2008-01-30       Impact factor: 5.157

10.  Solution 1H NMR investigation of Zn2+ and Cd2+ binding to amyloid-beta peptide (Abeta) of Alzheimer's disease.

Authors:  Christopher D Syme; John H Viles
Journal:  Biochim Biophys Acta       Date:  2005-10-14
View more
  13 in total

1.  How accurate are your simulations? Effects of confined aqueous volume and AMBER FF99SB and CHARMM22/CMAP force field parameters on structural ensembles of intrinsically disordered proteins: Amyloid-β42 in water.

Authors:  Orkid Coskuner Weber; Vladimir N Uversky
Journal:  Intrinsically Disord Proteins       Date:  2017-10-30

2.  Characterization of the internal dynamics and conformational space of zinc-bound amyloid β peptides by replica-exchange molecular dynamics simulations.

Authors:  Liang Xu; Xiaojuan Wang; Xicheng Wang
Journal:  Eur Biophys J       Date:  2013-05-03       Impact factor: 1.733

Review 3.  Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology.

Authors:  Orkid Coskuner-Weber; Vladimir N Uversky
Journal:  Int J Mol Sci       Date:  2018-01-24       Impact factor: 5.923

4.  Arginine and disordered amyloid-β peptide structures: molecular level insights into the toxicity in Alzheimer's disease.

Authors:  Orkid Coskuner; Olivia Wise-Scira
Journal:  ACS Chem Neurosci       Date:  2013-10-08       Impact factor: 4.418

5.  The structures of the E22Δ mutant-type amyloid-β alloforms and the impact of E22Δ mutation on the structures of the wild-type amyloid-β alloforms.

Authors:  Orkid Coskuner; Olivia Wise-Scira; George Perry; Taizo Kitahara
Journal:  ACS Chem Neurosci       Date:  2012-12-18       Impact factor: 4.418

6.  Structures of the E46K mutant-type α-synuclein protein and impact of E46K mutation on the structures of the wild-type α-synuclein protein.

Authors:  Olivia Wise-Scira; Aquila Dunn; Ahmet K Aloglu; Isin T Sakallioglu; Orkid Coskuner
Journal:  ACS Chem Neurosci       Date:  2013-01-30       Impact factor: 4.418

7.  Structures and free energy landscapes of the wild-type and A30P mutant-type α-synuclein proteins with dynamics.

Authors:  Olivia Wise-Scira; Ahmet Kemal Aloglu; Aquila Dunn; Isin Tuna Sakallioglu; Orkid Coskuner
Journal:  ACS Chem Neurosci       Date:  2013-01-30       Impact factor: 4.418

8.  Divalent copper ion bound amyloid-β(40) and amyloid-β(42) alloforms are less preferred than divalent zinc ion bound amyloid-β(40) and amyloid-β(42) alloforms.

Authors:  Orkid Coskuner
Journal:  J Biol Inorg Chem       Date:  2016-09-22       Impact factor: 3.358

9.  Structures and free energy landscapes of the A53T mutant-type α-synuclein protein and impact of A53T mutation on the structures of the wild-type α-synuclein protein with dynamics.

Authors:  Orkid Coskuner; Olivia Wise-Scira
Journal:  ACS Chem Neurosci       Date:  2013-05-17       Impact factor: 4.418

10.  Effects of Zn2+ binding on the structural and dynamic properties of amyloid β peptide associated with Alzheimer's disease: Asp1 or Glu11?

Authors:  Liang Xu; Xiaojuan Wang; Xicheng Wang
Journal:  ACS Chem Neurosci       Date:  2013-09-13       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.